James N. Topper

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Palo Alto, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Anne Marie Cook, Attorney-in-Fact for James Topper
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for James N. Topper

Form 4 holding Director, 10%+ Owner

ANAPTYSBIO, INC

Security class
Restricted Stock Unit
Shares / value
3,900
Estimated value
$85,059
Report date
06 Jan 2023
Price
$21.81
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

ALPINE IMMUNE SCIENCES, INC.

Security class
Common Stock
Shares / value
0
Estimated value
$0
Report date
18 May 2024
Price
$6.33
Ownership
By Frazier Life Sciences VIII, L.P.
Form 4 holding Director, 10%+ Owner

ANAPTYSBIO, INC

Security class
Stock Option (right to buy)
Shares / value
10,600
Estimated value
Report date
06 Jan 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

ALPINE IMMUNE SCIENCES, INC.

Security class
Stock Option (Right to buy)
Shares / value
0
Estimated value
Report date
20 May 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

ALPINE IMMUNE SCIENCES, INC.

Security class
Warrant (Right to Buy)
Shares / value
0
Estimated value
Report date
25 Apr 2024
Price
Ownership
By: Frazier Life Sciences VIII, L.P.
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by James N. Topper

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .